| Management of the adverse effects of lenalidomide in multiple myeloma. | |
| | |
MedLine Citation:
|
PMID: 21431626 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The introduction of new agents in the treatment of multiple myeloma, such as thalidomide, bortezomib, or lenalidomide, has represented an important step forward in the management of this disease, with improvement in both treatment response and patient survival. On the other hand, when new drugs are used it is very important to know their associated toxicity, since adequate management of the adverse effects can help to avoid unnecessary treatment interruptions - thereby undoubtedly contributing to improvement in the efficacy of therapy. The present study reviews the main hematological and nonhematological adverse effects potentially associated with the use of lenalidomide in its most common combinations used for the treatment of multiple myeloma, and the recommendations for dealing with such effects. |
| | |
Authors:
|
Ana Pilar González Rodríguez |
Related Documents
:
|
21325946 - Reduction of exposure in the management of occupational asthma. 21480996 - The risks of high ultrafiltration rate in chronic hemodialysis: implications for patien... 20678106 - Aortic complications of giant cell arteritis: a diagnostic and management dilemma. 16427536 - Anesthetic implications of traumatic pulmonary hernia repair. 19361896 - Recent developments in the design and synthesis of hybrid molecules based on aminoquino... 16362356 - Arthroscopic fibular sesamoidectomy in the management of the sesamoid osteomyelitis. |
Publication Detail:
|
Type: Journal Article Date: 2011-03-09 |
Journal Detail:
|
Title: Advances in therapy Volume: 28 Suppl 1 ISSN: 1865-8652 ISO Abbreviation: Adv Ther Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-03-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8611864 Medline TA: Adv Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 1-10 Citation Subset: T |
Affiliation:
|
Hematology Department, Hospital Central de Asturias, Oviedo, Asturias, Spain, anapilargonzalez@gmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT(3) ag...
Next Document: Lenalidomide treatment for patients with multiple myeloma: Diagnosis and management of most frequent...